ASPG and acute lymphoblastic leukemia: Asparaginase administration results in rapid and complete deamination of the amino acid asparagine and, to a lesser extent, glutamine, leading to depletion of asparagine in the plasma.39 Despite its application as an essential drug used in all treatment protocols for ALL, asparaginase is associated with a unique set of side effect that limits its clinical outcomes.